1847 Holdings LLC (NYSE American:EFSH), a publicly traded holding company platform that combines the attractive attributes of private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, announced the closing of its underwritten public offering of 1,428,572 Common Shares at a public offering price of $4.20 per share. The gross proceeds from this offering, before deducting underwriting discounts and commissions and other offering expenses payable by 1847 Holdings, was $6 million. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 214,286 Common Shares (equal to 15% of the Common Shares sold in the offering), at the public offering price less the underwriting discounts and commissions, to cover over-allotments, if any.

Greenwich LifeSciences, Inc. (NASDAQ: GLSI), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, announced the following:

• As previously disclosed, clinical trial contracts and budgets have been executed at multiple hospitals and the largest oncology network in the US. Clinical site initiation visits to train clinicians, nurses, coordinators, and pharmacists are underway, after which sites will be activated and the Flamingo-01 Phase III clinical trial will commence.
• The Company is continuing to make progress to initiate clinical sites in Europe through oncology networks, potentially including networks in Germany, Spain, and France.

EV Technology Group Ltd.(NEO: EVTG, OTCQB: EVTGF, DE: B96A) announced that its strategic partner MOKE International Limited, working with its distribution partner MOKE France SAS, has opened the doors of its new flagship store in its spiritual home, Saint-Tropez, France. Additionally, it has launched a brand-new website offering the unique MOKE experience online, where potential owners across the UK and Europe can configure their Electric MOKE and pay GBP£990 to secure their pre-orders and join the waiting list.

The new website gives customers the freedom to decide between having a new Electric MOKE delivered to a convenient address of their choice, or to collect it in person at Casa MOKE, situated in one of the world’s most glamourous locales.

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office (CIPO) for its patent application, CA 2937649, entitled "Abuse and Misuse Deterrent Transdermal Systems," that protects its AVERSA™ transdermal abuse deterrent technology.  Nutriband's AVERSA™ abuse deterrent technology can be utilized to incorporate aversive agents into transdermal patches to prevent the abuse, diversion, misuse and accidental exposure of drugs with abuse potential such as opioids used to treat moderate to severe chronic pain, while making sure that these drugs remain accessible to those patients who really need them.